• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 4.17% 2.5¢

ACTINOGEN MEDICAL LIMITED - Announcements

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

ACW ramps up alzheimer’s treatment trial

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

ACW Application for quotation of securities - ACW01/12/23 download Created with Sketch. 30.38KB
ACW Appendix 3Y-Dr George Morstyn28/11/23 download Created with Sketch. 194.64KB
ACW Appendix 3Y-Dr Geoff Brooke28/11/23 download Created with Sketch. 194.89KB
ACW Notification of cessation of securities - ACW28/11/23 download Created with Sketch. 21.61KB
ACW Actinogen receives $4.8 million R&D tax incentive rebatePRICE SENSITIVE28/11/23 download Created with Sketch. 224.74KB
ACW ACW XanaCIDD trial enrolment exceeds 50 percent28/11/23 download Created with Sketch. 221.05KB
ACW Amended Constitution17/11/23 download Created with Sketch. 420.34KB
ACW Results of AGM17/11/23 download Created with Sketch. 237.83KB
ACW Actinogen 2023 AGM - Chairs address and CEOs presentation17/11/23 download Created with Sketch. 2.48MB
ACW ACW CEO presents at Bell Potter Healthcare Conference 202315/11/23 download Created with Sketch. 3.15MB
ACW Application for quotation of securities - ACW08/11/23 download Created with Sketch. 26.71KB
ACW Actinogen appoints William Souter as new CFO08/11/23 download Created with Sketch. 239.79KB
ACW Amendment to Actinogen 2023 AGM resolutions 6 to 1027/10/23 download Created with Sketch. 212.49KB
ACW ACW CMO presents academic poster at CTAD 2023 conference25/10/23 download Created with Sketch. 592.86KB
ACW ACW CEO presentation for meetings at BIO Investor Forum USA18/10/23 download Created with Sketch. 3.33MB
ACW Actinogen September quarterly activity report & Appendix 4CPRICE SENSITIVE16/10/23 download Created with Sketch. 511.35KB
ACW Annual Report to Shareholders13/10/23 download Created with Sketch. 4.19MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form13/10/23 download Created with Sketch. 714.25KB
ACW Notification of cessation of securities - ACW11/10/23 download Created with Sketch. 21.52KB
ACW ACW CEO presents to Dementia Trials Australia conference06/10/23 download Created with Sketch. 1.69MB
ACW ACW presents to the Asian Society Against Dementia congress29/09/23 download Created with Sketch. 1.54MB
ACW Change in substantial holding27/09/23 download Created with Sketch. 166.64KB
ACW Notification of buy-back - ACW27/09/23 download Created with Sketch. 21.78KB
ACW Date of AGM and Closing Date for Director Nominations27/09/23 download Created with Sketch. 174.05KB
ACW Actinogen enhances XanaMIA Phase 2b Alzheimers trialPRICE SENSITIVE26/09/23 download Created with Sketch. 219.7KB
ACW Change in substantial holding20/09/23 download Created with Sketch. 166.67KB
ACW Notification regarding unquoted securities - ACW15/09/23 download Created with Sketch. 27.49KB
ACW Application for quotation of securities - ACW15/09/23 download Created with Sketch. 24.81KB
ACW Appendix 3Y-Mr Malcolm McComas12/09/23 download Created with Sketch. 195.82KB
ACW Appendix 3Y-Dr George Morstyn12/09/23 download Created with Sketch. 195.15KB
ACW Appendix 3Y-Dr Steven Gourlay12/09/23 download Created with Sketch. 194.14KB
ACW Appendix 3Y-Dr Geoffrey Brooke12/09/23 download Created with Sketch. 241.05KB
ACW Notification regarding unquoted securities - ACW11/09/23 download Created with Sketch. 23.88KB
ACW Application for quotation of securities - ACW11/09/23 download Created with Sketch. 24.91KB
ACW Actinogen closes successful $10 million rights issue offerPRICE SENSITIVE07/09/23 download Created with Sketch. 218.02KB
ACW Prof Paul Maruff & Dr Dana Hilt webinar & slide deck31/08/23 download Created with Sketch. 1.37MB
ACW Actinogen FY2023 results, following the sciencePRICE SENSITIVE30/08/23 download Created with Sketch. 269.85KB
ACW Appendix 4G30/08/23 download Created with Sketch. 286.39KB
ACW Corporate Governance Statement30/08/23 download Created with Sketch. 372.33KB
ACW ACW Appendix 4E and 2023 Annual ReportPRICE SENSITIVE30/08/23 download Created with Sketch. 4.11MB
ACW ACW secures further $0.5m rights issue shortfall commitmentPRICE SENSITIVE30/08/23 download Created with Sketch. 224.98KB
ACW ACW appoints company for rights issue shareholder contact30/08/23 download Created with Sketch. 269.47KB
ACW Prof Paul Maruff on neuroscience drug development & Xanamem29/08/23 download Created with Sketch. 217.16KB
ACW Letter to Ineligible Shareholders17/08/23 download Created with Sketch. 213.3KB
ACW Letter to Eligible Shareholders - Rights Issue Opens17/08/23 download Created with Sketch. 270.52KB
ACW ACW secures shortfall commitments of $4.56m for rights issuePRICE SENSITIVE15/08/23 download Created with Sketch. 222.88KB
ACW Entitlement Offer ProspectusPRICE SENSITIVE08/08/23 download Created with Sketch. 1.26MB
ACW Proposed issue of securities - ACW02/08/23 download Created with Sketch. 33.77KB
ACW Actinogen announces $10 million rights offerPRICE SENSITIVE02/08/23 download Created with Sketch. 259.74KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/07/23 download Created with Sketch. 330.43KB
ACW Trading HaltPRICE SENSITIVE31/07/23 download Created with Sketch. 642.62KB
ACW ACW CEO presents at Bioshares Biotech Summit25/07/23 download Created with Sketch. 2.7MB
ACW Actinogen CMO presents academic poster to AAIC Conference17/07/23 download Created with Sketch. 622.82KB
ACW ACW CEO presentation on emerging oral Alzheimers therapies21/06/23 download Created with Sketch. 1.49MB
ACW ACW CEO & CMO present at BIO International Convention05/06/23 download Created with Sketch. 1.52MB
ACW ACW AD trial amendment and Clinical Science Forum slidesPRICE SENSITIVE24/05/23 download Created with Sketch. 1.69MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE24/04/23 download Created with Sketch. 325.71KB
ACW Actinogen CMO presents at ADPD 2023 conference31/03/23 download Created with Sketch. 1.38MB
ACW Application for quotation of securities - ACW20/03/23 download Created with Sketch. 26.61KB
ACW Appendix 3X - Dr Nicki Vasquez01/03/23 download Created with Sketch. 149.99KB
ACW ACW appoints Dr Nicki Vasquez as a Non-Executive Director01/03/23 download Created with Sketch. 244KB
ACW Actinogen CEO presents to Spark Plus Biotech conference24/02/23 download Created with Sketch. 1.71MB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE22/02/23 download Created with Sketch. 1.33MB
ACW Actinogen appoints Dr Dana Hilt as Chief Medical Officer01/02/23 download Created with Sketch. 240.38KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/01/23 download Created with Sketch. 389.51KB
ACW ACW CEO presentation Sachs Neuroscience and JPM week09/01/23 download Created with Sketch. 1.54MB
ACW Letter to Shareholders - CEO 2022 Review & Outlook22/12/22 download Created with Sketch. 394.21KB
ACW FDA agrees to six-month Phase 2b Alzheimers Disease TrialPRICE SENSITIVE22/12/22 download Created with Sketch. 235.52KB
ACW Cleansing Notice09/12/22 download Created with Sketch. 205.68KB
ACW Application for quotation of securities - ACW09/12/22 download Created with Sketch. 24.71KB
ACW First patient treated in XanaCIDD Phase 2 Depression TrialPRICE SENSITIVE08/12/22 download Created with Sketch. 230.87KB
ACW Actinogen poster presentation at CTAD conference 202205/12/22 download Created with Sketch. 516.21KB
ACW Constitution16/11/22 download Created with Sketch. 424.43KB
ACW Results of AGM16/11/22 download Created with Sketch. 234.15KB
ACW Actinogen AGM Chair address & CEO presentation16/11/22 download Created with Sketch. 2.42MB
ACW Appendix 3Y - Dr George Morstyn11/11/22 download Created with Sketch. 192.7KB
ACW Cleansing Notice11/11/22 download Created with Sketch. 204.85KB
ACW Application for quotation of securities - ACW11/11/22 download Created with Sketch. 24.76KB
ACW ACW CEO presentation to Bell Potter Healthcare Conference09/11/22 download Created with Sketch. 2.76MB
ACW Appendix 3Y - Dr Steven Gourlay04/11/22 download Created with Sketch. 190.59KB
ACW Actinogen CEO presentation to Spark Plus Healthcare Day03/11/22 download Created with Sketch. 2.31MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/22 download Created with Sketch. 489.86KB
ACW Actinogen CEO presentation to ShareCafe investor webinar21/10/22 download Created with Sketch. 2.04MB
ACW R&D tax incentive rebate receivedPRICE SENSITIVE20/10/22 download Created with Sketch. 204.95KB
ACW Annual Report to Shareholders14/10/22 download Created with Sketch. 7.5MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form14/10/22 download Created with Sketch. 854.98KB
ACW ACW clinical biomarker study webcast presentationPRICE SENSITIVE10/10/22 download Created with Sketch. 2.4MB
ACW ACW announces positive Alzheimers Disease clinical resultsPRICE SENSITIVE10/10/22 download Created with Sketch. 300.23KB
ACW Trading HaltPRICE SENSITIVE06/10/22 download Created with Sketch. 272.6KB
ACW Date of AGM and Closing Date for Director Nominations28/09/22 download Created with Sketch. 204.74KB
ACW Actinogen AD Biomarkers Context & History Presentation13/09/22 download Created with Sketch. 2.94MB
ACW Appendix 4G25/08/22 download Created with Sketch. 285.67KB
ACW Corporate Governance Statement25/08/22 download Created with Sketch. 380.16KB
ACW Actinogen FY22 Results - Accelerating Clinical DevelopmentPRICE SENSITIVE25/08/22 download Created with Sketch. 254.15KB
ACW ACW Appendix 4E and 2022 Annual ReportPRICE SENSITIVE25/08/22 download Created with Sketch. 4.92MB
ACW Actinogen Spark Plus non deal roadshow investor presentation11/08/22 download Created with Sketch. 1.9MB
ACW Actinogen Clinical Trials Science Forum presentation slides03/08/22 download Created with Sketch. 5.15MB
ACW ACW CEO presentation to Spark Plus Aust Equities Day28/07/22 download Created with Sketch. 3.3MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/22 download Created with Sketch. 348.85KB
ACW ACW CEO to present at Spark Plus Aust Equities Day25/07/22 download Created with Sketch. 218.79KB
ACW Application for quotation of securities - ACW
01/12/23 download Created with Sketch. 30.38KB
ACW Appendix 3Y-Dr George Morstyn
28/11/23 download Created with Sketch. 194.64KB
ACW Appendix 3Y-Dr Geoff Brooke
28/11/23 download Created with Sketch. 194.89KB
ACW Notification of cessation of securities - ACW
28/11/23 download Created with Sketch. 21.61KB
ACW Actinogen receives $4.8 million R&D tax incentive rebate
28/11/23PRICE SENSITIVE download Created with Sketch. 224.74KB
ACW ACW XanaCIDD trial enrolment exceeds 50 percent
28/11/23 download Created with Sketch. 221.05KB
ACW Amended Constitution
17/11/23 download Created with Sketch. 420.34KB
ACW Results of AGM
17/11/23 download Created with Sketch. 237.83KB
ACW Actinogen 2023 AGM - Chairs address and CEOs presentation
17/11/23 download Created with Sketch. 2.48MB
ACW ACW CEO presents at Bell Potter Healthcare Conference 2023
15/11/23 download Created with Sketch. 3.15MB
ACW Application for quotation of securities - ACW
08/11/23 download Created with Sketch. 26.71KB
ACW Actinogen appoints William Souter as new CFO
08/11/23 download Created with Sketch. 239.79KB
ACW Amendment to Actinogen 2023 AGM resolutions 6 to 10
27/10/23 download Created with Sketch. 212.49KB
ACW ACW CMO presents academic poster at CTAD 2023 conference
25/10/23 download Created with Sketch. 592.86KB
ACW ACW CEO presentation for meetings at BIO Investor Forum USA
18/10/23 download Created with Sketch. 3.33MB
ACW Actinogen September quarterly activity report & Appendix 4C
16/10/23PRICE SENSITIVE download Created with Sketch. 511.35KB
ACW Annual Report to Shareholders
13/10/23 download Created with Sketch. 4.19MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form
13/10/23 download Created with Sketch. 714.25KB
ACW Notification of cessation of securities - ACW
11/10/23 download Created with Sketch. 21.52KB
ACW ACW CEO presents to Dementia Trials Australia conference
06/10/23 download Created with Sketch. 1.69MB
ACW ACW presents to the Asian Society Against Dementia congress
29/09/23 download Created with Sketch. 1.54MB
ACW Change in substantial holding
27/09/23 download Created with Sketch. 166.64KB
ACW Notification of buy-back - ACW
27/09/23 download Created with Sketch. 21.78KB
ACW Date of AGM and Closing Date for Director Nominations
27/09/23 download Created with Sketch. 174.05KB
ACW Actinogen enhances XanaMIA Phase 2b Alzheimers trial
26/09/23PRICE SENSITIVE download Created with Sketch. 219.7KB
ACW Change in substantial holding
20/09/23 download Created with Sketch. 166.67KB
ACW Notification regarding unquoted securities - ACW
15/09/23 download Created with Sketch. 27.49KB
ACW Application for quotation of securities - ACW
15/09/23 download Created with Sketch. 24.81KB
ACW Appendix 3Y-Mr Malcolm McComas
12/09/23 download Created with Sketch. 195.82KB
ACW Appendix 3Y-Dr George Morstyn
12/09/23 download Created with Sketch. 195.15KB
ACW Appendix 3Y-Dr Steven Gourlay
12/09/23 download Created with Sketch. 194.14KB
ACW Appendix 3Y-Dr Geoffrey Brooke
12/09/23 download Created with Sketch. 241.05KB
ACW Notification regarding unquoted securities - ACW
11/09/23 download Created with Sketch. 23.88KB
ACW Application for quotation of securities - ACW
11/09/23 download Created with Sketch. 24.91KB
ACW Actinogen closes successful $10 million rights issue offer
07/09/23PRICE SENSITIVE download Created with Sketch. 218.02KB
ACW Prof Paul Maruff & Dr Dana Hilt webinar & slide deck
31/08/23 download Created with Sketch. 1.37MB
ACW Actinogen FY2023 results, following the science
30/08/23PRICE SENSITIVE download Created with Sketch. 269.85KB
ACW Appendix 4G
30/08/23 download Created with Sketch. 286.39KB
ACW Corporate Governance Statement
30/08/23 download Created with Sketch. 372.33KB
ACW ACW Appendix 4E and 2023 Annual Report
30/08/23PRICE SENSITIVE download Created with Sketch. 4.11MB
ACW ACW secures further $0.5m rights issue shortfall commitment
30/08/23PRICE SENSITIVE download Created with Sketch. 224.98KB
ACW ACW appoints company for rights issue shareholder contact
30/08/23 download Created with Sketch. 269.47KB
ACW Prof Paul Maruff on neuroscience drug development & Xanamem
29/08/23 download Created with Sketch. 217.16KB
ACW Letter to Ineligible Shareholders
17/08/23 download Created with Sketch. 213.3KB
ACW Letter to Eligible Shareholders - Rights Issue Opens
17/08/23 download Created with Sketch. 270.52KB
ACW ACW secures shortfall commitments of $4.56m for rights issue
15/08/23PRICE SENSITIVE download Created with Sketch. 222.88KB
ACW Entitlement Offer Prospectus
08/08/23PRICE SENSITIVE download Created with Sketch. 1.26MB
ACW Proposed issue of securities - ACW
02/08/23 download Created with Sketch. 33.77KB
ACW Actinogen announces $10 million rights offer
02/08/23PRICE SENSITIVE download Created with Sketch. 259.74KB
ACW Quarterly Activity Report & Appendix 4C
31/07/23PRICE SENSITIVE download Created with Sketch. 330.43KB
ACW Trading Halt
31/07/23PRICE SENSITIVE download Created with Sketch. 642.62KB
ACW ACW CEO presents at Bioshares Biotech Summit
25/07/23 download Created with Sketch. 2.7MB
ACW Actinogen CMO presents academic poster to AAIC Conference
17/07/23 download Created with Sketch. 622.82KB
ACW ACW CEO presentation on emerging oral Alzheimers therapies
21/06/23 download Created with Sketch. 1.49MB
ACW ACW CEO & CMO present at BIO International Convention
05/06/23 download Created with Sketch. 1.52MB
ACW ACW AD trial amendment and Clinical Science Forum slides
24/05/23PRICE SENSITIVE download Created with Sketch. 1.69MB
ACW Quarterly Activity Report & Appendix 4C
24/04/23PRICE SENSITIVE download Created with Sketch. 325.71KB
ACW Actinogen CMO presents at ADPD 2023 conference
31/03/23 download Created with Sketch. 1.38MB
ACW Application for quotation of securities - ACW
20/03/23 download Created with Sketch. 26.61KB
ACW Appendix 3X - Dr Nicki Vasquez
01/03/23 download Created with Sketch. 149.99KB
ACW ACW appoints Dr Nicki Vasquez as a Non-Executive Director
01/03/23 download Created with Sketch. 244KB
ACW Actinogen CEO presents to Spark Plus Biotech conference
24/02/23 download Created with Sketch. 1.71MB
ACW Appendix 4D & Half-Year Financial Statements
22/02/23PRICE SENSITIVE download Created with Sketch. 1.33MB
ACW Actinogen appoints Dr Dana Hilt as Chief Medical Officer
01/02/23 download Created with Sketch. 240.38KB
ACW Quarterly Activity Report & Appendix 4C
30/01/23PRICE SENSITIVE download Created with Sketch. 389.51KB
ACW ACW CEO presentation Sachs Neuroscience and JPM week
09/01/23 download Created with Sketch. 1.54MB
ACW Letter to Shareholders - CEO 2022 Review & Outlook
22/12/22 download Created with Sketch. 394.21KB
ACW FDA agrees to six-month Phase 2b Alzheimers Disease Trial
22/12/22PRICE SENSITIVE download Created with Sketch. 235.52KB
ACW Cleansing Notice
09/12/22 download Created with Sketch. 205.68KB
ACW Application for quotation of securities - ACW
09/12/22 download Created with Sketch. 24.71KB
ACW First patient treated in XanaCIDD Phase 2 Depression Trial
08/12/22PRICE SENSITIVE download Created with Sketch. 230.87KB
ACW Actinogen poster presentation at CTAD conference 2022
05/12/22 download Created with Sketch. 516.21KB
ACW Constitution
16/11/22 download Created with Sketch. 424.43KB
ACW Results of AGM
16/11/22 download Created with Sketch. 234.15KB
ACW Actinogen AGM Chair address & CEO presentation
16/11/22 download Created with Sketch. 2.42MB
ACW Appendix 3Y - Dr George Morstyn
11/11/22 download Created with Sketch. 192.7KB
ACW Cleansing Notice
11/11/22 download Created with Sketch. 204.85KB
ACW Application for quotation of securities - ACW
11/11/22 download Created with Sketch. 24.76KB
ACW ACW CEO presentation to Bell Potter Healthcare Conference
09/11/22 download Created with Sketch. 2.76MB
ACW Appendix 3Y - Dr Steven Gourlay
04/11/22 download Created with Sketch. 190.59KB
ACW Actinogen CEO presentation to Spark Plus Healthcare Day
03/11/22 download Created with Sketch. 2.31MB
ACW Quarterly Activity Report & Appendix 4C
28/10/22PRICE SENSITIVE download Created with Sketch. 489.86KB
ACW Actinogen CEO presentation to ShareCafe investor webinar
21/10/22 download Created with Sketch. 2.04MB
ACW R&D tax incentive rebate received
20/10/22PRICE SENSITIVE download Created with Sketch. 204.95KB
ACW Annual Report to Shareholders
14/10/22 download Created with Sketch. 7.5MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form
14/10/22 download Created with Sketch. 854.98KB
ACW ACW clinical biomarker study webcast presentation
10/10/22PRICE SENSITIVE download Created with Sketch. 2.4MB
ACW ACW announces positive Alzheimers Disease clinical results
10/10/22PRICE SENSITIVE download Created with Sketch. 300.23KB
ACW Trading Halt
06/10/22PRICE SENSITIVE download Created with Sketch. 272.6KB
ACW Date of AGM and Closing Date for Director Nominations
28/09/22 download Created with Sketch. 204.74KB
ACW Actinogen AD Biomarkers Context & History Presentation
13/09/22 download Created with Sketch. 2.94MB
ACW Appendix 4G
25/08/22 download Created with Sketch. 285.67KB
ACW Corporate Governance Statement
25/08/22 download Created with Sketch. 380.16KB
ACW Actinogen FY22 Results - Accelerating Clinical Development
25/08/22PRICE SENSITIVE download Created with Sketch. 254.15KB
ACW ACW Appendix 4E and 2022 Annual Report
25/08/22PRICE SENSITIVE download Created with Sketch. 4.92MB
ACW Actinogen Spark Plus non deal roadshow investor presentation
11/08/22 download Created with Sketch. 1.9MB
ACW Actinogen Clinical Trials Science Forum presentation slides
03/08/22 download Created with Sketch. 5.15MB
ACW ACW CEO presentation to Spark Plus Aust Equities Day
28/07/22 download Created with Sketch. 3.3MB
ACW Quarterly Activity Report & Appendix 4C
28/07/22PRICE SENSITIVE download Created with Sketch. 348.85KB
ACW ACW CEO to present at Spark Plus Aust Equities Day
25/07/22 download Created with Sketch. 218.79KB
(20min delay)
Last
2.5¢
Change
0.001(4.17%)
Mkt cap ! $73.62M
Open High Low Value Volume
2.5¢ 2.5¢ 2.4¢ $64.83K 2.646M

Buyers (Bids)

No. Vol. Price($)
20 3924751 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 3226651 6
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
Last
2.5¢
  Change
0.001 ( 4.17 %)
Open High Low Volume
2.5¢ 2.5¢ 2.5¢ 762057
Last updated 15.44pm 01/11/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.